General Science
Nuzolvence (zoliflodacin) and Blujepa (gepotidacin)
- The U.S. Food and Drug Administration (FDA) has approved two new oral medicines for the treatment of gonorrhoea – Nuzolvence (zoliflodacin) and Blujepa (gepotidacin).
- Gonorrhoea is a common sexually transmitted infection (STI).
- The World Health Organization (WHO) has classified the gonorrhoea-causing bacterium Neisseria gonorrhoeae as a “high-priority” pathogen.
